ATE79550T1 - Die proteinabsorption verbessernde stoffe. - Google Patents

Die proteinabsorption verbessernde stoffe.

Info

Publication number
ATE79550T1
ATE79550T1 AT88108205T AT88108205T ATE79550T1 AT E79550 T1 ATE79550 T1 AT E79550T1 AT 88108205 T AT88108205 T AT 88108205T AT 88108205 T AT88108205 T AT 88108205T AT E79550 T1 ATE79550 T1 AT E79550T1
Authority
AT
Austria
Prior art keywords
toxic salt
protein absorption
improving substances
hydroxylamine
absorption improving
Prior art date
Application number
AT88108205T
Other languages
English (en)
Inventor
Stanley Jay Dr Sarnoff
Burton E Dr Sobel
Original Assignee
Survival Technology
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Survival Technology filed Critical Survival Technology
Application granted granted Critical
Publication of ATE79550T1 publication Critical patent/ATE79550T1/de

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/4151,2-Diazoles
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • A61K38/16Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/38Albumins
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • A61K38/16Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/43Enzymes; Proenzymes; Derivatives thereof
    • A61K38/46Hydrolases (3)
    • A61K38/48Hydrolases (3) acting on peptide bonds (3.4)
    • A61K38/49Urokinase; Tissue plasminogen activator
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/16Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing nitrogen, e.g. nitro-, nitroso-, azo-compounds, nitriles, cyanates
    • A61K47/18Amines; Amides; Ureas; Quaternary ammonium compounds; Amino acids; Oligopeptides having up to five amino acids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/0019Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Immunology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Zoology (AREA)
  • Biomedical Technology (AREA)
  • Dermatology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicinal Preparation (AREA)
AT88108205T 1987-05-28 1988-05-21 Die proteinabsorption verbessernde stoffe. ATE79550T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US07/054,898 US4839170A (en) 1985-10-01 1987-05-28 Protein absorption enhancing agents
EP88108205A EP0292908B1 (de) 1987-05-28 1988-05-21 Die Proteinabsorption verbessernde Stoffe

Publications (1)

Publication Number Publication Date
ATE79550T1 true ATE79550T1 (de) 1992-09-15

Family

ID=21994232

Family Applications (1)

Application Number Title Priority Date Filing Date
AT88108205T ATE79550T1 (de) 1987-05-28 1988-05-21 Die proteinabsorption verbessernde stoffe.

Country Status (8)

Country Link
US (1) US4839170A (de)
EP (1) EP0292908B1 (de)
JP (1) JPS63297331A (de)
AT (1) ATE79550T1 (de)
AU (1) AU627125B2 (de)
CA (1) CA1335788C (de)
DE (1) DE3873825T2 (de)
IL (1) IL86443A0 (de)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3939346A1 (de) * 1989-11-29 1991-06-06 Behringwerke Ag Arzneimitel zur subkutanen oder intramuskulaeren applikation enthaltend polypeptide
IL267689B2 (en) 2016-12-31 2025-05-01 Bioxcel Therapeutics Inc Use of sublingual dexmedetomidine for the treatment of agitation
BR112020026672A2 (pt) 2018-06-27 2021-03-30 Bioxcel Therapeutics, Inc. Formulações de filme contendo dexmedetomidina e métodos para produzi-las
BR112022000992A2 (pt) 2019-07-19 2022-06-14 Arx Llc Regimes de tratamento de dexmedetomidina não sedantes
US11806334B1 (en) 2023-01-12 2023-11-07 Bioxcel Therapeutics, Inc. Non-sedating dexmedetomidine treatment regimens

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4661469A (en) * 1984-08-08 1987-04-28 Survival Technology, Inc. t-PA composition capable of being absorbed into the blood stream and method of administration
US4656034A (en) * 1985-05-20 1987-04-07 Survival Technology, Inc. Absorption enhancing agents
US4658830A (en) * 1984-08-08 1987-04-21 Survival Technology, Inc. Method and apparatus for initiating reperfusion treatment by an unattended individual undergoing heart attack symptoms
EP0214281B1 (de) * 1985-03-06 1992-09-09 Survival Technology, Inc. Mittel zur absorptionsverbesserung von proteinen
ZA861695B (en) * 1985-03-06 1986-10-29 Survival Technology T-pa composition and method of getting into blood stream

Also Published As

Publication number Publication date
EP0292908A1 (de) 1988-11-30
DE3873825T2 (de) 1993-06-24
JPS63297331A (ja) 1988-12-05
US4839170A (en) 1989-06-13
EP0292908B1 (de) 1992-08-19
IL86443A0 (en) 1988-11-15
CA1335788C (en) 1995-06-06
AU1616488A (en) 1988-12-01
AU627125B2 (en) 1992-08-13
DE3873825D1 (de) 1992-09-24

Similar Documents

Publication Publication Date Title
ATE113213T1 (de) Gerät zur vorläufigen reperfusionsbehandlung von herzanfallsymptomen.
CA1024868A (en) Reagent and method for determining leukocytes and hemoglobin in the blood
AU562938B2 (en) 7, 10, 13, 16 docosatetraenoic acid composition
EP0191056A4 (de) T-pa zusammensetzung und verfahren zu deren aufnahme in den blutstrom.
DE3851473D1 (de) Haarkosmetisches Präparat.
DK0454898T3 (da) Glycosaminoglycan-modificeret protein, fremgangsmåde til fremstilling af proteinet, farmaceutiske præparater indeholdende proteinet samt anvendelse af proteinet
IE890580L (en) Therapeutic agent for the prevention of intraventricular hemorrhage in premature infants
DK0414078T3 (da) Disubstituerede (quinolin-2-yl-methoxy)phenyleddikesyrederivater
ATE79550T1 (de) Die proteinabsorption verbessernde stoffe.
DE3871791D1 (de) Verwendung von homo- und copolymeren des vinylalkohols zum tablettieren von wirkstoffen.
JPS5328133A (en) Novel compound having lipidddepleting activity in blood*process for preparation thereof and pharmaceutical composition containing these
DK325289A (da) Strontiumsalt, fremgangsmaade til fremstilling heraf samt farmaceutiske midler indeholdende saltet
ATE47829T1 (de) 5,9-dimethylheptadecan verfahren und mittel zur bekaempfung der fleckenminiermotte leucoptera scitella.
EP0214281A4 (de) Mittel zur absorptionsverbesserung von proteinen.
FR2603284B1 (fr) Derives d'acide 7-oxabicyclo(2.2.1.)heptane hydroxamique a action therapeutique
EP0191814A4 (de) Absorptionsverbesserer für proteine.
AU1751488A (en) The use of polyvinylpyrrolidone (pvp) to reduce the turbidity of sera, sera containing pvp, and a process for the preparation thereof
FI843695A7 (fi) Insuliini-johdannaisia, joissa B 30-asema on modifioitu, menetelmiä niiden valmistamiseksi ja niiden käyttö sekä sokeritaudin hoitoon tarkoitettuja lääkeaineita.
EP0410652A3 (en) Improvement of excretion of potassium ion by prostanoic acid derivatives
AU482810B2 (en) Reagent and method for determining leukocytes and hemoglobin inthe blood
HU209389B (en) Method for producing tetrasodium salt of 1,4,10,13-tetraoxa-7,16-diaza-cyclooctadecane-n,n'-dimalonic acid with sodium bromide content and one for producing medical preparatives containing said compound
HUT61619A (en) Method for radioimmunological derminic 5-hydroxi- 6,8,11,14-eicosatetraen- acid content of the biological samples
UA8124A1 (uk) Спосіб регенераціі н-катіоніту
GT198500045A (es) Una composicion para la higiene oral

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties